Skip to main content
SpringerLink
Log in

Pulmonary Complications in Cancer Patients

  • Chapter
  • First Online:
Oncologic Emergency Medicine

  • 1401 Accesses

Abstract

The recent advances of cancer treatment allow patients with many types of cancer to survive longer. This prolonged survival may be affected by pulmonary complications caused by the primary malignancy or its treatments. The pulmonary system is very sensitive to injuries and complications of cancer therapy. Pulmonary complications in cancer patients are common and sometimes can be fatal. They may involve the pulmonary parenchyma, vessels, and the pleural space. Emergency department physicians are often at the front line in diagnosing and treating cancer patients with pulmonary complications. Early diagnosis requires a high index of suspicion, accurate history taking (including recent or old cancer therapy), and targeted initial testing. Early intervention and managing emergent situations are as important as seeking appropriate specialized consultation promptly.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9(8):730–56.

    Article  PubMed  Google Scholar 

  2. Cfdcapanci AUSDoHaHS. U.S. Cancer Statistics Working Group. United States cancer statistics: 1999–2005 Incidence and Mortality Web-based Report.

    Google Scholar 

  3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. Cancer J Clin. 2008;58(2):71–96.

    Article  Google Scholar 

  4. Hauser MJ, Tabak J, Baier H. Survival of patients with cancer in a medical critical care unit. Arch Intern Med. 1982;142(3):527–9.

    Article  CAS  PubMed  Google Scholar 

  5. Herridge MS, Tansey CM, Matte A, Tomlinson G, Diaz-Granados N, Cooper A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364(14):1293–304.

    Article  CAS  PubMed  Google Scholar 

  6. Staudinger T, Stoiser B, Mullner M, Locker GJ, Laczika K, Knapp S, et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med. 2000;28(5):1322–8.

    Article  CAS  PubMed  Google Scholar 

  7. Soares M, Salluh JI, Spector N, Rocco JR. Characteristics and outcomes of cancer patients requiring mechanical ventilatory support for >24 hrs. Crit Care Med. 2005;33(3):520–6.

    Article  PubMed  Google Scholar 

  8. Pastores SM. Acute respiratory failure in critically ill patients with cancer. Diagnosis and management. Crit Care Clin. 2001;17(3):623–46.

    Article  CAS  PubMed  Google Scholar 

  9. Azoulay E, Schlemmer B. Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med. 2006;32(6):808–22.

    Article  PubMed  Google Scholar 

  10. Varon J, Marik PE. Cardiopulmonary resuscitation in patients with cancer. Am J Hosp Palliat Care. 2007;24(3):224–9.

    Article  PubMed  Google Scholar 

  11. Force ADT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–33.

    Google Scholar 

  12. Soubani AO, Shehada E, Chen W, Smith D. The outcome of cancer patients with acute respiratory distress syndrome. J Crit Care. 2014;29(1):183. e7–e12.

    Article  Google Scholar 

  13. Wang Y, Qian J, Li BR. Risk factors and outcome of acute respiratory distress syndrome in pediatric patients with cancer. Chin J Pediatr. 2007;4(3):232–3.

    Google Scholar 

  14. Mokart D, van Craenenbroeck T, Lambert J, Textoris J, Brun JP, Sannini A, et al. Prognosis of acute respiratory distress syndrome in neutropenic cancer patients. Eur Respir J. 2012;40(1):169–76.

    Article  PubMed  Google Scholar 

  15. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet. 2007;369(9572):1553–64.

    Article  PubMed  Google Scholar 

  16. Azoulay E, Lemiale V, Mokart D, Pene F, Kouatchet A, Perez P, et al. Acute respiratory distress syndrome in patients with malignancies. Intensive Care Med. 2014;40(8):1106–14.

    Article  PubMed  Google Scholar 

  17. Minne L, Abu-Hanna A, de Jonge E. Evaluation of SOFA-based models for predicting mortality in the ICU: a systematic review. Crit Care. 2008;12(6):R161.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Fuller BM, Mohr NM, Dettmer M, Kennedy S, Cullison K, Bavolek R, et al. Mechanical ventilation and acute lung injury in emergency department patients with severe sepsis and septic shock: an observational study. Acad Emerg Med. 2013;20(7):659–69.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Zhan Q, Sun B, Liang L, Yan X, Zhang L, Yang J, et al. Early use of noninvasive positive pressure ventilation for acute lung injury: a multicenter randomized controlled trial. Crit Care Med. 2012;40(2):455–60.

    Article  PubMed  Google Scholar 

  20. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2002;342(18):1301–8.

    Google Scholar 

  21. Broccard AF, Hotchkiss JR, Vannay C, Markert M, Sauty A, Feihl F, et al. Protective effects of hypercapnic acidosis on ventilator-induced lung injury. Am J Respir Crit Care Med. 2001;164(5):802–6.

    Article  CAS  PubMed  Google Scholar 

  22. Sinclair SE, Kregenow DA, Lamm WJ, Starr IR, Chi EY, Hlastala MP. Hypercapnic acidosis is protective in an in vivo model of ventilator-induced lung injury. Am J Respir Crit Care Med. 2002;166(3):403–8.

    Article  PubMed  Google Scholar 

  23. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004;351(4):327–36.

    Article  PubMed  Google Scholar 

  24. Meade MO, Cook DJ, Guyatt GH, Slutsky AS, Arabi YM, Cooper DJ, et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2008;299(6):637–45.

    Article  CAS  PubMed  Google Scholar 

  25. Mercat A, Richard JC, Vielle B, Jaber S, Osman D, Diehl JL, et al. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2008;299(6):646–55.

    Article  CAS  PubMed  Google Scholar 

  26. Alhazzani W, Alshahrani M, Jaeschke R, Forel JM, Papazian L, Sevransky J, et al. Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care. 2013;17(2):R43.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363(12):1107–16.

    Article  CAS  PubMed  Google Scholar 

  28. de Lassence A, Timsit JF, Tafflet M, Azoulay E, Jamali S, Vincent F, et al. Pneumothorax in the intensive care unit: incidence, risk factors, and outcome. Anesthesiology. 2006;104(1):5–13.

    Article  PubMed  Google Scholar 

  29. Engdahl O, Toft T, Boe J. Chest radiograph – a poor method for determining the size of a pneumothorax. Chest. 1993;103(1):26–9.

    Article  CAS  PubMed  Google Scholar 

  30. Mandavia DP, Joseph A. Bedside echocardiography in chest trauma. Emerg Med Clin North Am. 2004;22(3):601–19.

    Article  PubMed  Google Scholar 

  31. Lichtenstein DA. Ultrasound examination of the lungs in the intensive care unit. Pediatr Crit Care Med. 2009;10(6):693–8.

    Article  PubMed  Google Scholar 

  32. Chan SN, Okuno SH, Jatoi A. Causes and outcomes of spontaneous pneumothoraces in solid tumor cancer patients: an update for the medical oncologist. J Thorac Oncol. 2006;1(4):335–8.

    Article  PubMed  Google Scholar 

  33. Wiener RS, Schwartz LM, Woloshin S, Welch HG. Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records. Ann Intern Med. 2011;155(3):137–44.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Choi CM, Um SW, Yoo CG, Kim YW, Han SK, Shim YS, et al. Incidence and risk factors of delayed pneumothorax after transthoracic needle biopsy of the lung. Chest. 2004;126(5):1516–21.

    Article  PubMed  Google Scholar 

  35. Duncan DR, Morgenthaler TI, Ryu JH, Daniels CE. Reducing iatrogenic risk in thoracentesis: establishing best practice via experiential training in a zero-risk environment. Chest. 2009;135(5):1315–20.

    Article  PubMed  Google Scholar 

  36. Steinke K. Radiofrequency ablation of pulmonary tumours: current status. Cancer Imaging. 2008;8:27–35.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Zheng A, Wang X, Yang X, Wang W, Huang G, Gai Y, et al. Major complications after lung microwave ablation: a single-center experience on 204 sessions. Ann Thorac Surg. 2014;98(1):243–8.

    Article  PubMed  Google Scholar 

  38. Baumann MH, Strange C, Heffner JE, Light R, Kirby TJ, Klein J, et al. Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement. Chest. 2001;119(2):590–602.

    Article  CAS  PubMed  Google Scholar 

  39. Henry M, Arnold T, Harvey J. BTS guidelines for the management of spontaneous pneumothorax. Thorax. 2003;58 Suppl 2:39–52.

    Article  Google Scholar 

  40. Heffner JE, Klein JS. Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc. 2008;83(2):235–50.

    Article  PubMed  Google Scholar 

  41. Putnam Jr JB. Malignant pleural effusions. Surg Clin North Am. 2002;82(4):867–83.

    Article  PubMed  Google Scholar 

  42. Feller-Kopman D, Berkowitz D, Boiselle P, Ernst A. Large-volume thoracentesis and the risk of reexpansion pulmonary edema. Ann Thorac Surg. 2007;84(5):1656–61.

    Article  PubMed  Google Scholar 

  43. Parulekar W, Di Primio G, Matzinger F, Dennie C, Bociek G. Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions. Chest. 2001;120(1):19–25.

    Article  CAS  PubMed  Google Scholar 

  44. Hogg JR, Caccavale M, Gillen B, McKenzie G, Vlaminck J, Fleming CJ, et al. Tube thoracostomy: a review for the interventional radiologist. Semin Intervent Radiol. 2011;28(1):39–47.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Fidan A, Ozdogan S, Oruc O, Salepci B, Ocal Z, Caglayan B. Hemoptysis: a retrospective analysis of 108 cases. Respir Med. 2002;96(9):677–80.

    Article  CAS  PubMed  Google Scholar 

  46. Cho YJ, Murgu SD, Colt HG. Bronchoscopy for bevacizumab-related hemoptysis. Lung Cancer. 2007;56(3):465–8.

    Article  PubMed  Google Scholar 

  47. Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med. 2006;355(24):2542–50.

    Article  CAS  PubMed  Google Scholar 

  48. Ibrahim WH. Massive haemoptysis: the definition should be revised. Eur Respir J. 2008;32(4):1131–2.

    Article  CAS  PubMed  Google Scholar 

  49. Jean-Baptiste E. Clinical assessment and management of massive hemoptysis. Crit Care Med. 2000;28(5):1642–7.

    Article  CAS  PubMed  Google Scholar 

  50. Yoon W, Kim JK, Kim YH, Chung TW, Kang HK. Bronchial and nonbronchial systemic artery embolization for life-threatening hemoptysis: a comprehensive review. Radiographics. 2002;22(6):1395–409.

    Article  PubMed  Google Scholar 

  51. Cahill BC, Ingbar DH. Massive hemoptysis. Assessment and management. Clin Chest Med. 1994;15(1):147–67.

    CAS  PubMed  Google Scholar 

  52. Rosenow 3rd EC, Limper AH. Drug-induced pulmonary disease. Semin Respir Infect. 1995;10(2):86–95.

    PubMed  Google Scholar 

  53. Snyder LS, Hertz MI. Cytotoxic drug-induced lung injury. Semin Respir Infect. 1988;3(3):217–28.

    CAS  PubMed  Google Scholar 

  54. Abid SH, Malhotra V, Perry MC. Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol. 2001;13(4):242–8.

    Article  CAS  PubMed  Google Scholar 

  55. Briasoulis E, Pavlidis N. Noncardiogenic pulmonary edema: an unusual and serious complication of anticancer therapy. Oncologist. 2001;6(2):153–61.

    Article  CAS  PubMed  Google Scholar 

  56. Cahill RA, Spitzer TR, Mazumder A. Marrow engraftment and clinical manifestations of capillary leak syndrome. Bone Marrow Transplant. 1996;18(1):177–84.

    CAS  PubMed  Google Scholar 

  57. Bhalla KS, Wilczynski SW, Abushamaa AM, Petros WP, McDonald CS, Loftis JS, et al. Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support. Am J Respir Crit Care Med. 2000;161(1):17–25.

    Article  CAS  PubMed  Google Scholar 

  58. Walden PA, Mitchell-Weggs PF, Coppin C, Dent J, Bagshawe KD. Pleurisy and methotrexate treatment. Br Med J. 1977;2(6091):867.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Everts CS, Westcott JL, Bragg DG. Methotrexate therapy and pulmonary disease. Radiology. 1973;107(3):539–43.

    Article  CAS  PubMed  Google Scholar 

  60. Azambuja E, Fleck JF, Batista RG, Menna Barreto SS. Bleomycin lung toxicity: who are the patients with increased risk? Pulm Pharmacol Ther. 2005;18(5):363–6.

    Article  CAS  PubMed  Google Scholar 

  61. Garipagaoglu M, Munley MT, Hollis D, Poulson JM, Bentel GC, Sibley G, et al. The effect of patient-specific factors on radiation-induced regional lung injury. Int J Radiat Oncol Biol Phys. 1999;45(2):331–8.

    Article  CAS  PubMed  Google Scholar 

  62. Castellino RA, Glatstein E, Turbow MM, Rosenberg S, Kaplan HS. Latent radiation injury of lungs or heart activated by steroid withdrawal. Ann Intern Med. 1974;80(5):593–9.

    Article  CAS  PubMed  Google Scholar 

  63. Arbetter KR, Prakash UB, Tazelaar HD, Douglas WW. Radiation-induced pneumonitis in the “nonirradiated” lung. Mayo Clin Proc. 1999;74(1):27–36.

    Article  CAS  PubMed  Google Scholar 

  64. Montagnana M, Cervellin G, Franchini M, Lippi G. Pathophysiology, clinics and diagnostics of non-thrombotic pulmonary embolism. J Thromb Thrombolysis. 2011;31(4):436–44.

    Article  PubMed  Google Scholar 

  65. Sakuma M, Fukui S, Nakamura M, Takahashi T, Kitamukai O, Yazu T, et al. Cancer and pulmonary embolism: thrombotic embolism, tumor embolism, and tumor invasion into a large vein. Circ J. 2006;70(6):744–9.

    Article  PubMed  Google Scholar 

  66. Ma SQ, Lin Y, Ying HY, Shao YJ, Li XY, Bai CM. Solid malignancies complicated with pulmonary embolism: clinical analysis of 120 patients. Chin Med J (Engl). 2010;123(1):29–33.

    Article  Google Scholar 

  67. Winterbauer RH, Elfenbein IB, Ball Jr WC. Incidence and clinical significance of tumor embolization to the lungs. Am J Med. 1968;45(2):271–90.

    Article  CAS  PubMed  Google Scholar 

  68. Veinot JP, Ford SE, Price RG. Subacute cor pulmonale due to tumor embolization. Arch Pathol Lab Med. 1992;116(2):131–4.

    CAS  PubMed  Google Scholar 

  69. Hough CL, Kallet RH, Ranieri VM, Rubenfeld GD, Luce JM, Hudson LD. Intrinsic positive end-expiratory pressure in Acute Respiratory Distress Syndrome (ARDS) Network subjects. Crit Care Med. 2005;33(3):527–32.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pulmonary and Critical Care, Cooper Medical School of Rowan University, Cooper University Hospital, Camden, NJ, USA

    Wissam Abouzgheib MD & R. Phillip Dellinger MD

  2. Adult Health Institute, The University of Texas MD Anderson Cancer Center, Camden, NJ, USA

    R. Phillip Dellinger MD

Authors
  1. Wissam Abouzgheib MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Phillip Dellinger MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Phillip Dellinger MD .

Editor information

Editors and Affiliations

  1. Houston, Texas, USA

    Knox H. Todd

  2. Portland, Oregon, USA

    Charles R. Thomas, Jr.

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Abouzgheib, W., Dellinger, R.P. (2016). Pulmonary Complications in Cancer Patients. In: Todd, K., Thomas, Jr., C. (eds) Oncologic Emergency Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-26387-8_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26387-8_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26385-4

  • Online ISBN: 978-3-319-26387-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation